Brought to you by 
Genetic Signatures raises $3.9mm in private placement; adds additional $7.6mm more in second tranche
21 Nov 2016
Executive Summary
Genetic Signatures Ltd. (Australian molecular diagnostics company) raised $3.9 (A$5.1mm) in an oversubscribed private placement of 10.9mm new shares at $0.36 (A$0.47; 18% discount to prior 10-day trading average). The company will use the proceeds for commercial expansion in Australia, the EU, and the US, for FDA regulatory approvals and for product development costs for its pipeline.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genetic Signatures raises $3.9mm in private placement; adds additional $7.6mm more in second tranche
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice